FDA Investigator Patsy J Domingo

Patsy J Domingo has conducted inspections on 141 sites in 10 countries as of 01 Dec 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
141
Last Inspection Date:
01 Dec 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Germany, France, Romania, Belgium, Canada, Hungary, Austria, United Kingdom of Great Britain and Northern Ireland, Ireland
FDA Investigators that have inspected at least one site in common with Patsy J Domingo:
Adam J Wilson, Addam S Reynolds, Adetutu M Gidado, Alan L Truong, Alan M Barker, Alan M Roberts, Alan P Kurtzberg, Alanna L Mussawwir Bias, Albinus M D'sa, Alice S Tsao, Amanda L Baskin, Amanda M Dunneback, Amy S Graf, Andrace L Deyampert, Andrea D Swingle, Andrea F White, Anh M Lac, Anita Narula, PhD, Ann Marie Montemurro, Ann Marie Schofield, Ann Raju Daniel, Anthony F Lorenzo, Anthony R Petriella, Arsen Karapetyan, Art O Czabaniuk, Aurora Miha Trifanov, Ava M Bowman, Azza Talaat, Barbara A Rusin, Barbara Janine Breithaupt, Bei Y He, Benjamin J Smith, Bo Chi, PhD, Bonita S Chester, Brandy N Lepage, Brent M Dehaan, Brentley S Collins, Brian M Campbell, Brian P Putz, Brittany D Terhar, Bruce D Meade, Bruce H Mccullough, Burnell M Henry, Byungja E Marciante, Carl A Huffman, III, Carla J Lundi, Carmen M Faraianu, Caroline H Le, Caroline Strasinger, Carolyn J Oyster, Catherine V Quinlan, Cathie S Marshall, CDR Donald Ertel, CDR Ileana Barreto Pettit, Charisse K Green, Charles I Ann, Charles L Zhou, Charles M Spyr, Charles R Cote, RIC, Cheng H Yen, Cheryl A Clausen, Cheryl A Fuhs, Cheryl Love Harris, Cheryl M Monroe, Christian D Lynch (CDL), Christine A Harman, PhD, Constantin Y Philopoulos, Corrine M Carter, Courtney E Hillier, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia L Aycock, Cynthia L Kelley, Cynthia Li, Danial S Hutchison, Daniel J Brown, Daniel J Grabicki, Daniel L Obrzut, Darren S Morgan, David A Paterson, David E Bailey, David G Eng, David J Gasparovich, David Perkins, Dawn C Olenjack, Deanna L Lampley, Debara R Reese, Debara Reese, Deborah M Trout, Denise L Burosh, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Dennis E Swartz, Devon Jenkins, Dina A Tallman, Don H Bark, PhD, Donald C Obenhuber, PhD, Donna Mwilliams Hill, PhD, Douglas A Campbell, Dr. Zhihao Qiu (Peter), PhD, Eboni S Funderburk, Edmund F Mrak, Jr, Eliezar Ramos, Elizabeth M Kelley, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Enrico Joset Mangahis, Ephrem Hunde, PhD, Eric S Pittman, Erica N Koory, Erika V Butler, Erin D Mccaffery, Felix Maldonado, Frederick F Razzaghi, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geraldine D Sanders, Gwyn G Dickinson, Hamet M Toure, PharmD MPH, Hans T Meyers, Helen B Ricalde, Holly Brevig, Ifueko Osemwota, Ivy E Sweeney, Jacek Cieslak, PhD, Jacob G Lutz, Jacqueline Mdiaz Albertini, James C Maclaughlin, James D Bridges, James E Szelc, James I Giefer, James K Ireland, James L Dunnie, Jr, James P Mcevoy, James R Evans, Janet L Bowen, Jawaid Hamid, Jean Blackston Hill, Jean Lhu Primmer, Jean Salemme, PhD, Jeffery B Medwid, PhD, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey O Hilgendorf, Jennifer A Kemp, Jennifer L Bridgewater, Jennifer L Schmidt, Jeremy W Rotton, Joan Johnson, Joanne E King, John P Mistler, Jonathan R Loving, Joohi Castelvetere, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose Martinez, Jr, Jose R Hernandez, Joseph A Piechocki, Joseph R Strelnik, Joseph T Madak, Judith A Jankowski, Julie D Bringger, Justine Tomasso, Kalavati Suvarna, PhD, Karen E D'orazio, Karen M Montgomery (KMM), Karen Takahashi, Katherine Szestypalow, Kathleen D Culver, Kathryn A Guardiola, Kathryn E Ogger, Kathryn G Brown, Keith A Schwartz, Kelley L Clark, Kenneth H Williams, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kip J Hanks, Kristin M Abaonza, Kristina L Conroy, L'oreal D Fowlkes, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Sexton, Lauren Iacono Connors, PhD, Lauren L Vajo, Lauren M Lilly, PhD, Laurie A Haxel, Laurimer Kuilan Torres, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Anastasia M Piliafas Brown, LCDR Debra Emerson, LCDR Michael H Tollon, Leigh Anne Myers, Leroy Terrelonge, Leslie A Paul, Liatte Kreuger, PharmD, Linda Thai, Lindsey Brown, PhD, Lindsey M Schwierjohann, Lisa J Joseph, Lisa M Bellows, Lisa P Oakes, Logan T Williams, Luella J Rossi, Luis A Dasta, Madushini Dharmasena, PhD, Mamta Gautam Basak, PhD, Margaret M Annes, Maria Estrella, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marsha W Major, Martha Sullivan Myrick, Martin R Vowell, Matthew B Casale, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Mercy Oyugi, Miah I Schneider, Michael A Taylor, Michael E Maselli, Michael L Casner, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Mihaly S Ligmond, Montgomery Montgomery, Karen M, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Mra Munizn, Muna Algharibeh, Myra K Casey, Nadeem I Chaudhry, Nailing Zhang, Nancy A Bellamy, Nancy F Scheraga, Nancy G Schmidt, Nancy N Bellamy, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Nicholas A Violand, Nicholas E Boyd, Nicholas J Presto, Nicholas L Paulin, Omotunde O Osunsanmi, Owens, Paige E Shelborne, Paranthaman Senthamaraikannan, Parul M Patel, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patrick L Wisor, Patty P Kaewussdangkul, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paula A Trost, Peng Zhou, Philip A Klimkewicz, Prabhu P Raju, Qiao Y Bobo, Qin Xu, Rabin N Ghoshal, Rachel C Harrington, Rafeeq A Habeeb, Ralph A Erickson, Ralph H Vocque, Raquel Gonzalez Rivera, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Rebecca Rodriguez, Regina T Brown, Reginald Walker, Renee L Rice, PhD, Reyes Candau Chacon, PhD, Richard W Thornton, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert L Lewis, Jr, Robert M Barbosa, Robert R Barbosa, Rochelle L Cross, Roger A Hartman, Roger F Zabinski, Rohn R Robertson, Ronald G Crawford, Ronald J Kozara, Rose Ashley, Rose Xu, Russell J Glapion, Russell K Riley, Ryan J Benedict, Salwa K Poole, Samantha J Bradley, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Sanket N Patel, Santos E Camara, Sarah B Tanksley, Sarah E Mcmullen, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Sarah Rhoades, Sargum C Sood, Scott A Golladay, Scott T Ballard, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shelby N Turner, Sherri J Jackson, Shirley J Berryman, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sneha S Patel, Soyinka S Eneng, Stephanie A Slater, MS, Stephen D Eich, Stephen J Koniers, Steven C Derrick, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susan T Hadman, Susanna E Ford, Suyang Qin, Tara R Gooen, Terri L Dodds, Theodore N Sietsema, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tina S Roecklein, Tonnie L Carter, Torrance J Slayton, Tracey Asinjen Wiersma, Tracey L Harris, Tracey L Siebesma, Tracey L Taylor, Twana R Chandler, Uduak M Inokon, Virgilio F Pacio, CSO, Vlada Matusovsky, Wayne E Seifert, William A Warnick, William C Gilbert, William D Tingley, William J Leonard, William R Brubaker, Xianghong Jing (Emily), PhD, Xiaokuang Lai, PhD, Yangmin Ning, Yasamin Ameri, Yiwei Li, Yumi J Hiramine, Yvesna C Blaise, Yvonne E Lozano

Patsy J Domingo's Documents

Publish Date Document Type Title
December, 2008 FDA 483 Caraco Pharmaceutical Laboratories, LTD. - Form 483, 2008-12-22
May, 2009 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2009-06-19
May, 2001 FDA 483 Response Takeda Ireland Limited - Form 483R, 2001-06-13
May, 2010 FDA 483 Tower Laboratories Ltd - Form 483, 2010-05-12
December, 2001 EIR Emergent Biodefense Operations Lansing LLC - EIR, 2001-12-19
May, 2005 EIR Eli Lilly and Company - EIR, 2005-05-19
March, 2003 EIR Pfizer Inc. - EIR, 2003-03-17
June, 2002 FDA 483 Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC - Form 483, 2002-06-18
July, 2000 FDA 483 ENDO USA, Inc. - Form 483, 2000-07-28
March, 2003 FDA 483 UCB Pharma S.A. - Form 483, 2003-03-28
August, 2001 FDA 483 Acura Pharmaceuticals, Inc. - Form 483, 2001-08-03
June, 2011 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2011-06-28
September, 2005 EIR Tower Laboratories Ltd - EIR, 2005-09-28
September, 2007 EIR L. Perrigo Company - EIR, 2007-09-13
April, 2010 FDA 483 DSC Laboratories, LLC - Form 483, 2010-04-13
March, 2000 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2000-03-10
August, 2002 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2002-08-08
December, 2000 FDA 483 Ash Stevens LLC - Form 483, 2000-12-21
March, 2001 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2001-03-21
September, 2004 FDA 483 Response L. Perrigo Company - Form 483R, 2004-09-21
June, 2003 FDA 483 Acura Pharmaceuticals, Inc. - Form 483, 2003-06-19
December, 2008 FDA 483 Caraco Pharmaceutical Laboratories, LTD. - Form 483, 2008-12-22
January, 2003 EIR Pharmacia & Upjohn Company LLC - EIR, 2003-01-30
November, 2008 FDA 483 L. Perrigo Company - Form 483, 2008-11-07
June, 2006 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2006-06-21
April, 2001 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2001-05-25
August, 2000 FDA 483 Contract Pharmaceuticals Ltd. - Form 483, 2000-08-11
August, 2000 EIR Contract Pharmaceuticals Ltd. - EIR, 2000-08-11
August, 2010 FDA 483 Aurorium LLC - Form 483, 2010-08-27
February, 2002 FDA 483 Baxter COMPASS - Form 483, 2002-02-07
February, 2005 FDA 483 Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC - Form 483, 2005-02-14
December, 2001 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2001-12-19
March, 2011 FDA 483 L. Perrigo Company - Form 483, 2011-03-21
June, 2008 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2008-06-11
November, 2008 FDA 483 Response L. Perrigo Company - Form 483R, 2008-12-04
September, 2000 EIR Nutrition & Biosciences USA 1, LLC - EIR, 2000-09-29
September, 2004 EIR L. Perrigo Company - EIR, 2004-09-08
August, 2000 EIR Contract Pharmaceuticals Limited Canada - EIR, 2000-09-19
March, 2003 EIR ENDO USA, Inc. - EIR, 2003-03-03
May, 2003 EIR Central Admixture Pharmacy Services, Inc. - EIR, 2003-05-23
January, 2003 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2003-01-30
May, 2003 FDA 483 Response Central Admixture Pharmacy Services, Inc. - Form 483R, 2003-05-23
March, 2001 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2001-03-07
February, 2001 FDA 483 Response ENDO USA, Inc. - Form 483R, 2001-03-30
September, 2007 FDA 483 L. Perrigo Company - Form 483, 2007-09-13
May, 2001 EIR GlaxoSmithKline - EIR, 2001-06-29
March, 2010 FDA 483 Future Pak LLC - Form 483, 2010-03-10
December, 2004 EIR ENDO USA, Inc. - EIR, 2004-12-06
January, 2004 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2004-01-30
April, 2001 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2001-04-25
July, 2009 FDA 483 DDP Specialty Electronic Materials US 9, LLC HIMS - Form 483, 2009-07-08
June, 2000 FDA 483 Morton International, Inc dba Morton Salt, Inc.. - Form 483, 2000-06-15
September, 2002 FDA 483 Wayne Chemical Inc. - Form 483, 2002-09-10
March, 2003 FDA 483 Response UCB Pharma S.A. - Form 483R, 2003-04-28
June, 2010 FDA 483 Vortech Pharmaceuticals, Ltd. - Form 483, 2010-06-28
September, 2006 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2006-09-29
April, 2009 EIR Caraco Pharmaceutical Laboratories, LTD. - EIR, 2009-04-09
May, 2005 FDA 483 Eli Lilly and Company - Form 483, 2005-05-19
June, 2004 FDA 483 Lannett Company, Inc. - Form 483, 2004-06-04
September, 2000 FDA 483 Nutrition & Biosciences USA 1, LLC - Form 483, 2000-09-29
September, 2003 FDA 483 Response Nutrition & Biosciences USA 1, LLC - Form 483R, 2003-10-10
November, 2011 FDA 483 Corium Innovations, Inc - Form 483, 2011-11-07
February, 2006 EIR ENDO USA, Inc. - EIR, 2006-02-08
December, 2006 EIR L. Perrigo Company - EIR, 2006-12-15
January, 2010 FDA 483 L. Perrigo Company - Form 483, 2010-01-14
December, 2003 EIR Eli Lilly and Company - EIR, 2003-12-05
January, 2008 FDA 483 Eli Lilly and Company - Form 483, 2008-01-31
March, 2006 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2006-03-21
August, 2005 FDA 483 Response L. Perrigo Company - Form 483R, 2005-09-15
September, 2002 FDA 483 Wayne Concept Manufacturing Co Inc - Form 483, 2002-09-10
September, 2001 FDA 483 Response Abbott Laboratories - Form 483R, 2001-09-28
December, 2006 FDA 483 Response L. Perrigo Company - Form 483R, 2007-01-09
May, 2001 FDA 483 Response GlaxoSmithKline - Form 483R, 2001-06-21
May, 2001 EIR Takeda Ireland Limited - EIR, 2001-06-14
May, 2005 FDA 483 Response Eli Lilly and Company - Form 483R, 2005-05-19
March, 2003 EIR UCB Pharma S.A. - EIR, 2003-03-28
May, 2009 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2009-05-12
May, 2003 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2003-05-23
September, 2003 EIR Nutrition & Biosciences USA 1, LLC - EIR, 2003-09-19
December, 2004 FDA 483 ENDO USA, Inc. - Form 483, 2004-12-06
April, 2001 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2001-04-25
March, 2004 FDA 483 Tykel Distributors - Form 483, 2004-03-03
March, 2000 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2000-03-10
June, 2004 EIR Lannett Company, Inc. - EIR, 2004-06-04
September, 2005 FDA 483 Response Tower Laboratories Ltd - Form 483R, 2005-11-02
November, 2007 FDA 483 Cayman Chemical Company, Inc. - Form 483, 2007-11-13
February, 2001 EIR ENDO USA, Inc. - EIR, 2001-02-15
September, 2004 FDA 483 L. Perrigo Company - Form 483, 2004-09-08
August, 2000 FDA 483 Response Contract Pharmaceuticals Ltd. - Form 483R, 2000-08-11
April, 2002 FDA 483 Response Siegfried PharmaChemikalien Minden GmbH - Form 483R, 2002-05-28
September, 2002 FDA 483 Vintage Chemical Inc - Form 483, 2002-09-11
July, 2000 EIR ENDO USA, Inc. - EIR, 2000-07-28
March, 2002 EIR Pharmacia & Upjohn Company LLC - EIR, 2002-03-14
September, 2003 FDA 483 The Dom Chemical Company - Form 483, 2003-09-19
March, 2001 EIR Pharmacia & Upjohn Company LLC - EIR, 2001-03-07
October, 2006 EIR King Pharmaceuticals LLC - EIR, 2006-10-26
April, 2002 FDA 483 Siegfried PharmaChemikalien Minden GmbH - Form 483, 2002-04-24
September, 2002 FDA 483 Oza Compound Products, LLC - Form 483, 2002-09-11
March, 2008 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2008-03-06
March, 2003 FDA 483 ENDO USA, Inc. - Form 483, 2003-03-03
June, 2011 EIR Nutrition & Biosciences USA 1, LLC - EIR, 2011-06-16
January, 2003 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2003-02-25
June, 2004 FDA 483 Response Lannett Company, Inc. - Form 483R, 2004-06-15
April, 2002 EIR Siegfried PharmaChemikalien Minden GmbH - EIR, 2002-04-24
June, 2008 FDA 483 Response Sun Pharmaceutical Industries, Inc. - Form 483R, 2008-07-10
August, 2005 EIR L. Perrigo Company - EIR, 2005-08-10
November, 2008 EIR L. Perrigo Company - EIR, 2008-11-07
July, 2003 EIR Pharmacia & Upjohn Company LLC - EIR, 2003-07-18
December, 2008 FDA 483 Response Caraco Pharmaceutical Laboratories, LTD. - Form 483R, 2009-01-21
August, 2005 FDA 483 L. Perrigo Company - Form 483, 2005-08-10
September, 2000 FDA 483 Response Nutrition & Biosciences USA 1, LLC - Form 483R, 2000-10-12
September, 2001 FDA 483 Abbott Laboratories - Form 483, 2001-09-28
December, 2001 FDA 483 ENDO USA, Inc. - Form 483, 2001-12-07
May, 2001 FDA 483 GlaxoSmithKline - Form 483, 2001-05-24
December, 2011 FDA 483 Ferndale Laboratories, Inc. - Form 483, 2011-12-13
September, 2010 FDA 483 Eli Lilly and Company - Form 483, 2010-09-03
May, 2001 FDA 483 Takeda Ireland Limited - Form 483, 2001-05-17
September, 2001 EIR Abbott Laboratories - EIR, 2001-09-28
October, 2002 FDA 483 U of M Nuclear Pharmacy - Form 483, 2002-10-18
December, 2006 FDA 483 L. Perrigo Company - Form 483, 2006-12-15
September, 2010 FDA 483 Baxter Pharmaceutical Solutions LLC - Form 483, 2010-09-23
October, 2001 FDA 483 Cayman Chemical Company, Inc. - Form 483, 2001-10-25
February, 2001 FDA 483 ENDO USA, Inc. - Form 483, 2001-02-15
June, 2002 EIR Ash Stevens LLC - EIR, 2002-06-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more